TrianglePUBLICATIONS · 17369574
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2007 Mar 20
- First author
- Blay JY
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Blay JY
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Ray-Coquard I
- type
- Author
- name
- Bui B
- type
- Author
- name
- Duffaud F
- type
- Author
- name
- Delbaldo C
- type
- Author
- name
- Adenis A
- type
- Author
- name
- Viens P
- type
- Author
- name
- Rios M
- type
- Author
- name
- Bompas E
- type
- Author
- name
- Cupissol D
- type
- Author
- name
- Guillemet C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Blay JY
- type
- Author
- name
- Le Cesne A
- type
- Author
- name
- Ray-Coquard I
- type
- Author
- name
- Bui B
- type
- Author
- name
- Duffaud F
- type
- Author
- name
- Delbaldo C
- type
- Author
- name
- Adenis A
- type
- Author
- name
- Viens P
- type
- Author
- name
- Rios M
- type
- Author
- name
- Bompas E
- type
- Author
- name
- Cupissol D
- type
- Author
- name
- Guillemet C
- type
- Author
- bibliography ids
- nci-bib-b25e314265734893a8ee8c1e
- book metadata
- content sha256
- 7c2749c99e56ef9794c9f66307e5f87717446f820ed22e6fac1ebd3d228bef0b
- document type
- citation
- dois
- 10.1200/JCO.2006.09.0183
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17369574
- immutable id
- pubmed:17369574@7c2749c99e56ef9794c9f66307e5f87717446f820ed22e6fac1ebd3d228bef0b
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 9
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1107-13
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 17369574
- provenance
- batch id
- e687ecc838c318f9ec65
- provider
- NCBI PubMed ESummary
- record sha256
- 33ecd2a32b59b1bfb2bf5cc9f0bee1fc4beaf08ec15b2ffc0379814dc74fd2f4
- response sha256
- 57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
- retrieved at
- 2026-09-09T23:46:11.674833+00:00
- publication date
- display
- 2007 Mar 20
- precision
- day
- year
- 2007
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
Preserved source evidence · Not medical advice